Oakworth Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $110K | Hold |
264
| – | – | 0.01% | 353 |
|
|
2026
Q1 | $77.3K | Sell |
264
-37
| -12% | -$12.2K | ﹤0.01% | 386 |
|
|
2025
Q4 | $106K | Buy |
301
+37
| +14% | +$12.5K | 0.01% | 334 |
|
|
2025
Q3 | $85.3K | Buy |
264
+19
| +8% | +$5.91K | ﹤0.01% | 373 |
|
|
2025
Q2 | $95.3K | Sell |
245
-93
| -28% | -$37.4K | 0.01% | 291 |
|
|
2025
Q1 | $147K | Hold |
338
| – | – | 0.01% | 243 |
|
|
2024
Q4 | $125K | Hold |
338
| – | – | 0.01% | 258 |
|
|
2024
Q3 | $176K | Hold |
338
| – | – | 0.01% | 219 |
|
|
2024
Q2 | $183K | Buy |
338
+228
| +207% | +$121K | 0.01% | 210 |
|
|
2024
Q1 | $57K | Hold |
110
| – | – | ﹤0.01% | 306 |
|
|
2023
Q4 | $51.9K | Hold |
110
| – | – | ﹤0.01% | 313 |
|
|
2023
Q3 | $47.9K | Sell |
110
-19
| -15% | -$8.62K | ﹤0.01% | 299 |
|
|
2023
Q2 | $57.3K | Buy |
129
+19
| +17% | +$8.77K | ﹤0.01% | 290 |
|
|
2023
Q1 | $50.6K | Hold |
110
| – | – | ﹤0.01% | 297 |
|
|
2022
Q4 | $56.4K | Hold |
110
| – | – | 0.01% | 268 |
|
|
2022
Q3 | $50K | Hold |
110
| – | – | 0.01% | 292 |
|
|
2022
Q2 | $53K | Hold |
110
| – | – | 0.01% | 293 |
|
|
2022
Q1 | $54K | Hold |
110
| – | – | ﹤0.01% | 296 |
|
|
2021
Q4 | $51K | Hold |
110
| – | – | ﹤0.01% | 329 |
|
|
2021
Q3 | $41K | Buy |
+110
| New | +$41.8K | ﹤0.01% | 333 |
|
|
2018
Q1 | – | Sell |
-19
| Closed | -$4K | – | 622 |
|
|
2017
Q4 | $4K | Hold |
19
| – | – | ﹤0.01% | 531 |
|
|
2017
Q3 | $4K | Hold |
19
| – | – | ﹤0.01% | 545 |
|
|
2017
Q2 | $4K | Hold |
19
| – | – | ﹤0.01% | 535 |
|
|
2017
Q1 | $3K | Hold |
19
| – | – | ﹤0.01% | 552 |
|
|
2016
Q4 | $3K | Hold |
19
| – | – | ﹤0.01% | 558 |
|
|
2016
Q3 | $2K | Hold |
19
| – | – | ﹤0.01% | 554 |
|
|
2016
Q2 | $3K | Hold |
19
| – | – | ﹤0.01% | 513 |
|
|
2016
Q1 | $3K | Hold |
19
| – | – | ﹤0.01% | 469 |
|
|
2015
Q4 | $3K | Hold |
19
| – | – | ﹤0.01% | 447 |
|
|
2015
Q3 | $3K | Hold |
19
| – | – | ﹤0.01% | 367 |
|
|
2015
Q2 | $3K | Hold |
19
| – | – | ﹤0.01% | 377 |
|
|
2015
Q1 | $3K | Hold |
19
| – | – | ﹤0.01% | 387 |
|
|
2014
Q4 | $2K | Hold |
19
| – | – | ﹤0.01% | 405 |
|
|
2014
Q3 | $2K | Hold |
19
| – | – | ﹤0.01% | 379 |
|
|
2014
Q2 | $2K | Hold |
19
| – | – | ﹤0.01% | 383 |
|
|
2014
Q1 | $2K | Hold |
19
| – | – | ﹤0.01% | 385 |
|
|
2013
Q4 | $2K | Buy |
+19
| New | +$1.69K | ﹤0.01% | 370 |
|
Other funds holding ELV
LMFP
HGIM
DC
CF
MIHAS
Oakworth Capital's ELV Position: Q2 2026 in Review
Oakworth Capital held its Elevance Health (ELV) position steady in Q2 2026 at 264 shares worth $110K. The position accounts for 0.01% of the portfolio, ranked #353.
Oakworth Capital first reported a position in ELV in Q4 2013 and has held it in 37 quarters since. The position peaked at $183K in Q2 2024. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Oakworth Capital held 264 shares of Elevance Health worth $110K as of Q2 2026.
- Oakworth Capital left its Elevance Health share count unchanged in Q2 2026.
- Elevance Health made up 0.01% of Oakworth Capital's portfolio in Q2 2026, its #353 holding.
- Oakworth Capital first reported a position in Elevance Health in Q4 2013 and has held it in 37 quarters since.
- Oakworth Capital's Elevance Health position peaked at $183K in Q2 2024.
- 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.